Bacteriotherapy in the Treatment of COVID-19

NCT04368351 · clinicaltrials.gov ↗

UNKNOWN

Status

70

Enrollment

OTHER

Sponsor class

Conditions

COVID
Pneumonia
Diarrhea

Interventions

DIETARY_SUPPLEMENT: SivoMixx (200 billion)
DRUG: Azithromycin
DRUG: hydroxychloroquine

Sponsor

University of Roma La Sapienza